IHS Chemical Week

World News and Views :: Top of the News

DSM Acquires U.S. Biotech R&D Firm, Microbia

1:37 AM MDT | September 22, 2010 | Natasha Alperowicz

DSM has announced the acquisition of Microbia Inc. (Lexington, MA) from Ironwood Pharmaceuticals. Terms of the deal were not disclosed. Microbia is an industrial biotechnology R&D firm with only limited sales. It has developed a "highly effective" technology platform for the production of high-quality natural carotenoids, including beta-carotene and canthaxanthin, as well as nutritional products and other specialty materials and chemicals from renewable resources. The acquisition will allow DSM to incorporate Microbia's proprietary platform and...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis from the entire global chemical enterprise on chemweek.com
  • Free mobile edition of Chemical Week
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional focus
  • Global outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.




contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa